Affinity of anti-spike antibodies to three major sars-cov-2 variants in recipients of three major vaccines

HIGHLIGHTS

• who: Patrick J. Macdonald from the (UNIVERSITY) have published the research work: Affinity of anti-spike antibodies to three major SARS-CoV-2 variants in recipients of three major vaccines, in the Journal: (JOURNAL)
• what: The authors compare the affinity of antibodies towards different types (variants) of SARS-CoV-2 viral protein in the serum of individuals who have been vaccinated with vaccines produced by Pfizer (Comirnaty) Moderna (Spikevax) and discovered that all three vaccines generated antibodies that strongly bind the original SARS-CoV-2 virus but the binding of the Delta variant was ten . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.